Dr. Mannis is new to Stanford and will add trials in the near future. His research focuses on the development of novel therapies for acute leukemia, with a particular interest in immunotherapy, targeted agents, and predictive biomarkers as a means to improve outcomes and quality of life for patients with hematologic malignancies.